recurrent platinum sensitive primary peritoneal cancer

DBCOND0128091Neoplasms

recurrent platinum sensitive primary peritoneal cancer is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.

Classified under: Neoplasms
Indicated drugs: Bevacizumab
Olaparib

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for recurrent platinum sensitive primary peritoneal cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account